RecruitingNCT04664569

National Bacterial Meningitis Study in Children and Newborns

National Observatory of Bacterial Meningitis in Children and Newborns

Sponsor

Association Clinique Thérapeutique Infantile du val de Marne

Enrollment

10,000 participants

Start Date

Jan 1, 2001

Study Type

OBSERVATIONAL

Conditions

Meningitis Children, Only Neonatal Infection Pneumococcal Conjugate Vaccine Antibiotic Treatment Meningococcal Vaccines H. Influenzae Vaccine Case Fatality Rate

Summary

Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in bacterial meningitis in children.

Eligibility

Min Age: 1 DayMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with antibiotic treatment, case fatality rate, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Day to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.